Group leader
Eva González-Suárez
Postdoctoral researchers
Adrian Sanz
Eva Maria Trinidad
Elayne Hondares
PhD students
Clara Gomez
Jorge Gomez
Sandra Benitez
Guillermo Yoldi
Marina Ciscar
Maria Zafeiroglou
Scientific production
9
PAPERS
64,772
TOTAL IF
7,197
MEAN IF
6 PUBLICATIONS IN FIRST QUARTILE
4 PUBLICATIONS IN FIRST DECILE
Highlights
- PLEIO-RANK: Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity. ERC Consolidator Grant, Eva González-Suárez, 2016.
- Yoldi G; Pellegrini P; Trinidad EM; Cordero A; Gómez-Miragaya J; Serra-Musach J; Dougall WC; Munoz P; Pujana M-A; Planelles L; Gonzalez-Suarez E. RANK signaling blockade reduces breast cancer recurrence by inducing tumor cell differentiation. Cancer Research 2016. DOI: 10.1158/0008-5472.CAN-15-2745
- Sigl, V; Owusu-Boaitey, K; Joshi, PA; Kavirayani, A; Wirnsberger, G; Novatchkova, M; Kozieradzki, I; Schramek, D; Edokobi, N; Hersl, J; Sampson, A; Odai-Afotey, A; Lazaro, C; Gonzalez-Suarez, E; Pujana, MA; Cimba, F; Heyn, H; Vidal, E; Cruickshank, J; Berman, H; Sarao, R; Ticevic, M; Uribesalgo, I; Tortola, L; Rao, S; Tan, Y; Pfeiler, G; Lee, EY; Bago-Horvath, Z; Kenner, L; Popper, H; Singer, C; Khokha, R; Jones, LP; Penninger, JM. RANKL/RANK control Brca1 mutation-driven mammary tumors. Cell Research 2016. DOI: 10.1038/cr.2016.69